Drugs / LY03009
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04593511 | Feb → Oct 2021 | Parkinson disease | Luye Pharma Group Ltd. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LY03009 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04593511 ↗ |
| Route | Intramuscular | “single intramuscular injection” NCT04593511 ↗ |